Cartiva

Cartiva

Developer of innovative products for the treatment of cartilage injuries and osteoarthritis.
  • Edit
DateInvestorsAmountRound
-

N/A

-

$4.3m

Series A

$1.5m

Debt
N/A

$1.5m

Early VC

$8.5m

Series D

$8.5m

Series E

$435m

Valuation: $435m

Acquisition
Total FundingAUD35.2m

Recent News about Cartiva

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.